J&J spinoff Kenvue forecasts upbeat annual profit on self-care boost
By Raghav Mahobe and Ananya Mariam Rajesh (Reuters) – Kenvue, the former consumer health unit of Johnson & Johnson, forecast full-year profit above Wall Street estimates on Thursday, betting on resilient demand for its skincare and self-care products such as Neutrogena and Tylenol. Shares of the company still fell as much as 10% after J&J,…